Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCLI | NCEL | CMMB | ||
| Company | Brainstorm Cell Theraputc | Newcelx Ltd | Chemomab Therapeutics Ltd ADR | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.9100 | 2.43 | 1.6800 | ||
| High | 0.9619 | 2.44 | 1.7300 | ||
| Low | 0.9100 | 2.40 | 1.5800 | ||
| Latest | 0.9249 | 2.43 | 1.5900 | ||
| Change | +0.0349 | +0.01 | +0.0200 | ||
| % Change | +3.92% | +0.41% | +1.27% | ||
| Volume | 6,334 | 5,210 | 56,849 | ||
| 20-Day Average Volume | 23,147 | 18,666 | 76,321 | ||
| Previous Close | 0.8900 | 2.42 | 1.5700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.7756 | 2.68 | 1.8577 | ||
| 20-Day Raw Stochastic | 88.00% | 13.51% | 26.26% | ||
| 20-Day Relative Strength | 66.18 | 40.00 | 43.95 | ||
| Weighted Alpha | +19.96 | -69.72 | -67.53 | ||
| Today's Opinion | 72% Buy | 96% Sell | 80% Sell | ||
| Previous Opinion | 56% Buy | 88% Sell | 80% Sell | ||
| Last Month's Opinion | 32% Sell | 56% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.43% since 03/18/26 | -6.87% since 03/18/26 | -20.50% since 03/18/26 | ||
| Low | 0.8003 on 03/23/26 | 2.34 on 03/23/26 | 1.5630 on 03/24/26 | ||
| High | 0.9699 on 03/24/26 | 2.54 on 03/19/26 | 2.0700 on 03/19/26 | ||
| 1-Month | |||||
| %Chg | +48.39% since 02/25/26 | -15.28% since 02/25/26 | +10.42% since 02/25/26 | ||
| Low | 0.5950 on 02/26/26 | 2.34 on 03/23/26 | 1.3600 on 02/26/26 | ||
| High | 0.9699 on 03/24/26 | 3.08 on 03/09/26 | 2.2359 on 03/17/26 | ||
| 3-Month | |||||
| %Chg | +56.76% since 12/24/25 | -7.22% since 12/24/25 | -15.43% since 12/24/25 | ||
| Low | 0.4589 on 02/13/26 | 1.89 on 12/31/25 | 1.3500 on 02/25/26 | ||
| High | 0.9699 on 03/24/26 | 3.25 on 02/10/26 | 2.2359 on 03/17/26 | ||
| 6-Month | |||||
| %Chg | +32.13% since 09/25/25 | -88.16% since 09/25/25 | -36.40% since 09/25/25 | ||
| Low | 0.4589 on 02/13/26 | 1.89 on 12/31/25 | 1.3500 on 02/25/26 | ||
| High | 0.9699 on 03/24/26 | 24.60 on 09/29/25 | 3.5800 on 10/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 9,821 | 11,031 | 9,663 | ||
| Shares Outstanding, K | 11,035 | 4,558 | 6,155 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -11,620,000 | -1,980,000 | -9,000,000 | ||
| Last Quarter Sales | 0 | N/A | 0 | ||
| Last Quarter Net Income | -2,110,000 | -5,847,000 | -1,870,000 | ||
| 60-Month Beta | 0.69 | 0.15 | 0.41 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.91 on 11/14/25 | N/A on 08/25/20 | -0.24 on 03/19/26 | ||
| Latest Earnings Date | 03/30/26 | 05/15/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||